Header Logo

Connection

Naoko Takebe to Paclitaxel

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Paclitaxel.
Naoko Takebe
Connection Strength
0.150
Paclitaxel
  1. A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors. Invest New Drugs. 2020 06; 38(3):855-865.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.